# Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease

> **NCT00305201** · PHASE2 · WITHDRAWN · sponsor: **Pontificia Universidad Catolica de Chile**

## Conditions studied

- Kawasaki Disease

## Interventions

- **DRUG:** pravastatin

## Key facts

- **NCT ID:** NCT00305201
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-04
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn due to lack of study participants
- **Last updated:** 2016-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00305201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00305201, "Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00305201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*